Biorelate, founded in 2014 and headquartered in the United Kingdom, is a key player in the intersection of Big Data, Biotechnology, Health Care, and Life Sciences. Their slogan, "The most advanced data curation in biopharma. Galactic AI™ is powered by the best of LLM, AI and NLP technology.", encapsulates their mission to aid scientists in navigating complex biomedical challenges.
The company offers an innovative knowledge graph that significantly enhances capabilities in knowledge review, target and biomarker discovery, understanding mechanisms of action, and expanding indications within biopharma. Their cutting-edge technological approach positions them as a leader in data solutions for the industry.
On 29 November 2022, Biorelate secured a £6.50M Series A investment. The round was backed by notable investors including Triple Point Ventures, Maven Capital Partners, YFM Equity Partners, amongst others, signaling strong confidence in their strategic direction and technological prowess.